Header Logo

Connection

Sheila Weinmann to Carcinoma, Intraductal, Noninfiltrating

This is a "connection" page, showing publications Sheila Weinmann has written about Carcinoma, Intraductal, Noninfiltrating.
  1. Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women With Low-Risk Ductal Carcinoma In Situ After Breast Conserving Surgery: The Impact of a 7-Gene Biosignature Based on 10-Year Ipsilateral Breast Recurrence Rates. Int J Radiat Oncol Biol Phys. 2025 Nov 15; 123(4):1090-1101.
    View in: PubMed
    Score: 0.235
  2. A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy. Int J Radiat Oncol Biol Phys. 2023 01 01; 115(1):93-102.
    View in: PubMed
    Score: 0.193
  3. HER2 evaluation and its impact on breast cancer treatment decisions. Public Health Genomics. 2012; 15(1):1-10.
    View in: PubMed
    Score: 0.088

© 2025 Kaiser Permanente

Your Privacy Choices